[
  {
    "ts": "2026-01-15T15:56:27+00:00",
    "headline": "JPM26: Intellia Therapeutics hopeful on CRISPR safety despite patient death",
    "summary": "Intellia Therapeutics CEO John Leonard explained the circumstances of the patient death at the JP Morgan Healthcare Conference 2026.",
    "url": "https://www.clinicaltrialsarena.com/news/jpm26-intellia-therapeutics-hopeful-on-crispr-safety-despite-patient-death/",
    "source": "Clinical Trials Arena",
    "provider": "yfinance",
    "raw": {
      "id": "398236db-5e88-3148-9b42-4245c07e74b3",
      "content": {
        "id": "398236db-5e88-3148-9b42-4245c07e74b3",
        "contentType": "STORY",
        "title": "JPM26: Intellia Therapeutics hopeful on CRISPR safety despite patient death",
        "description": "",
        "summary": "Intellia Therapeutics CEO John Leonard explained the circumstances of the patient death at the JP Morgan Healthcare Conference 2026.",
        "pubDate": "2026-01-15T15:56:27Z",
        "displayTime": "2026-01-15T15:56:27Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/clinical_trials_arena_396/6195bd9f5366bb54ed9c3eb56e72584a",
          "originalWidth": 1000,
          "originalHeight": 750,
          "caption": "Intellia Therapeutics announced the patient death in November 2025. Image credit: Piotr Swat / Shutterstock.com.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/GQsdacVLIOWDx0lRPRsz0A--~B/aD03NTA7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/clinical_trials_arena_396/6195bd9f5366bb54ed9c3eb56e72584a.cf.webp",
              "width": 1000,
              "height": 750,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/iBvibXD1S0_0wb.x5FsDww--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/clinical_trials_arena_396/6195bd9f5366bb54ed9c3eb56e72584a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Clinical Trials Arena",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.clinicaltrialsarena.com/news/jpm26-intellia-therapeutics-hopeful-on-crispr-safety-despite-patient-death/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/jpm26-intellia-therapeutics-hopeful-crispr-155627347.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NTLA"
            },
            {
              "symbol": "REGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]